Axsome Therapeutics, Inc. (AXSM)

Healthcare · Biotechnology · NASDAQ

Axsome Therapeutics, Inc. (AXSM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $10.64B and a free-cash-flow yield of -0.9%. Over the most recent reported fiscal year, revenue grew 65.5%.

Market cap	$10.64B
Trailing P/E	—
FCF yield	-0.9%
Revenue growth (YoY)	+65.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live AXSM data on Nama Insights →